Circulation Research. 1999;84:1203-1211
(Circulation Research. 1999;84:1203-1211.)
© 1999 American Heart Association, Inc.
Chemiluminescent Detection of Oxidants in Vascular Tissue
Lucigenin But Not Coelenterazine Enhances Superoxide Formation
Margaret M. Tarpey,
C. Roger White,
Edward Suarez,
Gloria Richardson,
Rafael Radi,
Bruce A. Freeman
From the Departments of Anesthesiology (M.M.T., G.R., B.A.F.), Medicine
(C.R.W.), and Biochemistry and Medical Genetics (B.A.F.), and the Center for
Free Radical Biology (M.M.T., C.R.W., B.A.F.), University of Alabama at
Birmingham, Birmingham, Ala, and Department of Biochemistry (E.S., R.R.),
Universidad de la Republica, Montevideo, Uruguay.
Correspondence to Margaret M. Tarpey, Department of Anesthesiology, University of Alabama at Birmingham, 619 19th St S, Birmingham, AL 35233. E-mail margaret.tarpey{at}ccc.uab.edu
 |
Abstract
|
|---|
AbstractLucigenin-amplified
chemiluminescence has frequently
been used to assess the formation of
superoxide in vascular
tissues. However, the ability of lucigenin to
undergo redox
cycling in purified enzyme-substrate mixtures has raised
questions
concerning the use of lucigenin as an appropriate probe for
the
measurement of superoxide production. Addition of lucigenin
to
reaction mixtures of xanthine oxidase plus NADH resulted in
increased
oxygen consumption, as well as superoxide
dismutaseinhibitable
reduction of cytochrome
c,
indicative of enhanced rates of superoxide
formation. Additionally, it
was revealed that lucigenin stimulated
oxidant formation by both
cultured bovine aortic endothelial
cells and isolated
rings from rat aorta. Lucigenin treatment
resulted in enhanced hydrogen
peroxide release from endothelial
cells, whereas
exposure to lucigenin resulted in inhibition
of
endothelium-dependent relaxation in isolated aortic
rings
that was superoxide dismutase inhibitable. In contrast, the
chemiluminescent
probe coelenterazine had no significant effect on
xanthine oxidasedependent
oxygen consumption,
endothelial cell hydrogen peroxide release,
or
endothelium-dependent relaxation. Study of enzyme and
vascular
systems indicated that coelenterazine chemiluminescence is a
sensitive
marker for detecting both superoxide and peroxynitrite.
Key Words: superoxide free radical lucigenin coelenterazine peroxynitrite
 |
Introduction
|
|---|
Superoxide (O
2
) and
other oxidants play a central role in the
maintenance of
vascular homeostasis and injury. Nitric oxide
(·NO)-dependent cell
signaling, including endothelium-dependent
relaxation,
is modulated by both O
2
and
superoxide dismutases
(SODs), the family of enzymes that catalyze the
formation of
hydrogen peroxide
(H
2O
2) and molecular oxygen
from O
2
.
1 2 3 4
Alterations in both the rates of formation and extents of
scavenging of
O
2
have been implicated in the
vascular dysfunction
seen in atherosclerosis,
hypertension, diabetes, and chronic
nitrate
tolerance.
5 6 7 8 9 10 Finally, increased rates of
vascular
production of O
2
contribute
to the initiation of proinflammatory
events, with transcriptional
regulation of the gene expression
of vascular cell adhesion molecule-1
and monocyte chemoattractant
protein-1 sensitive to changes in cellular
oxidant production.
11 12
Measurement of the vascular production of
O2
is problematic for
several reasons. Low intracellular steady-state concentrations occur as
a result of the balance between the endogenous rates of
partial reduction of oxygen to O2
and the scavenging of O2
by highly
efficient cytoplasmic and mitochondrial SODs, resulting in
intracellular O2
concentrations
estimated to rarely exceed 10 nmol/L.13 Extracellular
release of small proportions of intracellularly formed
O2
may occur via diffusion through
anion channels.14 15 Also,
O2
formed from plasma membrane-bound
oxidases remains at relatively low levels in vascular tissues because
of serum and extracellular fluid components, including low molecular
weight oxidant scavengers and the heparin-binding extracellular
SOD.3 16 17 18 19
Lucigenin-enhanced chemiluminescence has been used extensively as an
indicator of O2
production
by O2
-generating enzyme systems and
activated leukocytes20 21 22 23 and has been adopted
for use in the estimation of O2
production by cultured cell systems, tissue
homogenates, and intact vascular
tissue.2 24 25 26 Initial studies of mechanisms of
O2
-dependent lucigenin
chemiluminescence showed that lucigenin must first undergo univalent
reduction, before a secondary reaction with
O2
, to ultimately result in light
emission.27 More recently, lucigenin has been demonstrated
to undergo cycles of univalent reduction followed by auto-oxidation to
yield O2
, thus accelerating rates of
O2
generation by purified
enzyme-substrate complexes.28 29 30 31 Although no
lucigenin-dependent stimulation of cell
O2
production was apparent
from activated macrophages undergoing respiratory
burst,32 this is in contrast to results obtained when low
levels of O2
were
generated,32 a condition more reflective of oxidant
production in both normal and diseased vascular tissues. The
concentration-dependent enhancement by lucigenin of
O2
formation is particularly
troublesome in studies using vascular tissue, in which concentrations
of lucigenin from 50 to 500 µmol/L are typically used in an
attempt to amplify the chemiluminescent signal obtained from low rates
of O2
production. These
concerns led us to investigate the potential for lucigenin to enhance
endogenous rates of vascular oxidant production in
2 model systems, bovine aortic endothelial cells
(BAECs) in vitro and isolated rings from rat aorta, as well as its
ability to undergo redox cycling during enzymatic generation of low
levels of O2
. From these studies, we
reveal the limitations extant in the use of lucigenin to quantify
vascular O2
production. In
addition, the luminophore coelenterazine
(2-(4-hydroxybenzyl)-6-(4-hydroxyphenyl)-8-benzyl-3,7-dihydroimidazo[1,2-
]pyrazin-3-one)
has been reported to be useful in the detection of inflammatory
cell-derived O2
.33
Thus, purified enzymatic sources of
O2
and
H2O2 were used to describe
the oxidant-dependent chemiluminescence properties of coelenterazine
and its response to ·NO-derived metabolites as previously for
lucigenin and luminol.27 28 31 34 Both cell culture and
isolated aortic ring systems, in contrast to lucigenin, demonstrate the
absence of accelerated O2
generation
on exposure to up to 50 µmol/L coelenterazine, a concentration
almost 20-fold in excess of that required for maximal chemiluminescence
yield in purified enzymatic systems, affirming the utility of this
cell-permeant probe for the estimation of
O2
and peroxynitrite
(ONOO-) in biological systems.
 |
Materials and Methods
|
|---|
Chemicals and Reagents
FCS and iron-supplemented calf serum were acquired from Hyclone.
Cell
culture reagents were from GIBCO. SOD and
2,3-dimethoxy-1,4-naphthoquinone
(DMNQ) were obtained from OXIS, Inc.
Coelenterazine was from
Molecular Probes. Glucose oxidase (GO) and
xanthine oxidase
(XO) were obtained from Calbiochem. Manganese tetrakis
(
N-ethylpyridinium-2-yl)porphyrin
(T2E), an SOD mimetic, was
a gift from Dr Irwin Fridovich (Duke
University). All other
chemicals were purchased from Sigma.
Animals
Ten-week-old male Sprague-Dawley rats (300 to 325 g) were
obtained from Harlan, Inc (Wilmington, MA), for vascular function
analysis. All rats were maintained at constant humidity
(60±5%), temperature (24±1°C), and light cycle (6 AM
to 6 PM) and were fed a standard rat pellet diet (Ralston
Purina Diet) ad libitum. All protocols were approved by the
Institutional Animal Care and Use Committee at the University of
Alabama at Birmingham and were consistent with the Guide
for the Care and Use of Laboratory Animals (NIH publication 85-23,
revised 1985).
ONOO Synthesis
ONOO was synthesized as previously
described and treated with MnO2 to eliminate
residual H2O2.35
The concentration of ONOO- was determined
spectrophotometrically (
302=1.67
mmol/L-1 ·
cm-1),36 with working solutions of
ONOO- prepared by dilution in 0.1N NaOH and used
within 15 minutes.
Biochemical Analyses
XO activity was monitored spectrophotometrically by measuring
rates of uric acid production at 295 nm (
=11
mmol/L-1 · cm-1)
in 50 µmol/L xanthine and 50 mmol/L potassium phosphate
buffer, pH 7.4. GO activity was determined by polarographic measurement
of oxygen consumption of 5 to 10 U · mL-1
enzyme in 1 mmol/L glucose and 50 mmol/L potassium phosphate
buffer, pH 7.4. Extracellular release of
H2O2 from BAEC was measured
in cells incubated in HBSS by reaction of medium removed from cell
monolayers with ammonium ferrous sulfate and potassium
thiocyanate.37 38 Superoxide generation was measured by
the SOD-inhibitable reduction of 10 µmol/L oxidized cytochrome
c monitored spectrophotometrically at 550 nm, using
M=21 mmol/L-1
· cm-1.39
Chemiluminescence Measurements
Lucigenin- and coelenterazine-enhanced chemiluminescence was
monitored using a Thorn EMI photon counter equipped with an EMI Fact 50
Mk III photomultiplier cooled to 20°C. The voltage in the
photomultiplier was kept at 1500 V. Reactions were carried out in
continuously stirred glass tubes containing 3-mL reaction volumes
maintained at 37°C. Data acquisition and analysis were
performed with DQ software (DATAQ Instruments).
Cell Culture
BAECs were cultured in medium 199 with 5% newborn calf serum,
5% iron-supplemented calf serum, 100 U ·
mL-1 penicillin, and 100 µg ·
mL-1 streptomycin. Experiments were carried out
on subcultured passage 5 to passage 10 cells within 36 hours of
reaching confluence. The purity of cultures was determined on the basis
of their characteristic cobblestone morphology, positive
immunostaining for factor VIII antigen, and selective
incorporation of fluorescently labeled acetylated LDL.
Cellular protein content was measured by reaction with bicinchoninic
acid.40
Vessel Reactivity Studies
The effects of lucigenin and coelenterazine on
endothelium-dependent relaxation was assessed in
isolated rat aortic ring segments. Briefly, the aorta was excised and
placed in prewarmed and oxygenated Krebs-Henseleit buffer
and dissected free of fat and adhering tissue. Individual ring segments
(2 to 3 mm in width) were cut from vessels, and each vascular ring
was mounted on 2 stainless steel hooks and suspended from a
force-displacement transducer in a water-jacketed tissue bath. The ring
was anchored to a hook at the base of the chamber, and a passive load
of 2.0 g was applied to vessels. Ring segments were bathed in a
Krebs-Henseleit solution of the following composition (in mmol/L):
NaCl 118, KCl 4.6, NaHCO3 27.2,
KH2PO4 1.2,
MgSO4 1.2, CaCl2 1.75,
Na2-EDTA 0.03, and glucose 11.1 (pH 7.4). The
solution was continuously aerated with a 95% O2,
5% CO2 gas mixture unless specified and
maintained at 37°C. Changes in isometric tension were measured using
capacitative force transducers (Radnoti Glass Technology, Inc).
Real-time data were acquired and digitized using an IBM-compatible
computer and stored for later analysis using commercially
available software (Experimenter's Workbench, Datawave, Inc).
After an equilibration period of 45 minutes, ring segments were
depolarized with KCl (70 mmol/L) to determine the contractile
capacity of the vessel. Rings were then thoroughly washed and allowed
to equilibrate for an additional 45 minutes. All experiments were
performed in the presence of indomethacin (5
µmol/L) to eliminate the effects of
cyclooxygenase-derived vasoactive molecules. In
initial studies, ring segments were submaximally contracted with the
-adrenergic agonist phenylephrine (PE). When tension
development reached a plateau, ·NO-dependent relaxation was tested in
PE-contracted ring segments by cumulative exposure to acetylcholine
(ACh; 1x10-9 to 3x10-6
mol/L), an endothelium-dependent vasodilator. Vessels
were then thoroughly washed and allowed to recover for 1 hour. In the
next series of experiments, lucigenin (100 and 250 µmol/L) was
added to the tissue bath before the initiation of the PE/ACh protocol.
No effect of lucigenin on basal arterial tone was noted
under these conditions. In some experiments, the effect of lucigenin on
·NO-dependent relaxation was assessed in tissues that were treated
with 95% compressed air, 5% CO2. Recombinant
chimeric heparin binding human CuZn SOD (100 U ·
mL-1)10 or native bovine CuZn SOD
(200 U · mL-1) was added in some
experiments to the tissue bath 5 minutes before the addition of
lucigenin. In parallel experiments, the effects of coelenterazine (10
and 50 µmol/L) on ·NO-dependent relaxation were also tested.
As for experiments studying lucigenin effects on vascular function,
coelenterazine was added to the tissue bath before exposure to PE. All
experiments were performed in the dark to minimize potential
photochemical reactions of buffers, lucigenin, and coelenterazine
mediated by fluorescent light.
Vessel Chemiluminescence Studies
Similarly isolated vascular ring segments were incubated with
DMNQ (100 µmol/L) in the presence or absence of the SOD mimetic
MnT2E (100 µg · mL-1) in 50 mmol/L
potassium phosphate and 100 µmol/L EDTA, pH 7.4, for 3 hours at
37°C. Control rings were incubated with 0.95% ethanol, the vehicle
used to dissolve DMNQ. Ring segments were rinsed thoroughly, and
10 µmol/L coelenterazine was added to assess vascular
chemiluminescence.
Statistical Analysis
Comparisons between groups were made by use of 1-way ANOVA. When
significance was indicated, Student-Newman-Keuls post hoc
analysis was performed. P<0.05 was considered
significant.
 |
Results
|
|---|
Lucigenin-Dependent Oxidant Production
To study the effect of lucigenin on low rates of
O
2
formation,
as might be expected
in vascular tissues in contrast to the
high-output
O
2
production associated
with activated leukocytes,
the reduction of XO by NADH was used
as an exemplary reduced
flavoprotein.
32 Figure 1

demonstrates the effect of lucigenin
on
XO plus NADHdependent oxidation to yield
O
2
, as measured
by cytochrome
c reduction. In the presence of 150 µmol/L
NADH, 50
mU · mL
-1 XO reduced cytochrome
c at a rate
of 0.32 µmol/L ·
min
-1, with the rate of cytochrome
c
reduction diminished 93% by 30 U · mL
-1
SOD. The basal
rate of cytochrome
c reduction was increased
5-fold, to 1.64
µmol/L · min
-1 by
20 µmol/L lucigenin. Lucigenin-enhanced
cytochrome
c
reduction was inhibited 43% by SOD, to 0.94 µmol/L
·
min
-1. Addition of coelenterazine (10 and
50 µmol/L)
had no effect on the rate of XO plus NADHmediated
cytochrome
c reduction (data not shown). Table 1

depicts the rates of oxygen
consumption
by reaction systems under these conditions. Both
20 and 250
µmol/L lucigenin enhanced the rate of XO plus
NADHdependent oxygen
consumption, whereas 10 µmol/L
coelenterazine had no effect.
Lucigenin also mediated direct
(ie,
O
2
-independent) cytochrome
c reduction by XO, as indicated
by the significant fraction
(57%) of SOD-resistant cytochrome
c reduction
(Figure 1

). This direct reduction of cytochrome
c by
lucigenin was also investigated using GO plus glucose,
as
before.
28 At pH 7.4, GO plus glucose divalently
reduces
oxygen to H
2O
2,
with no O
2
formation detected by
assessment
of rates of cytochrome
c reduction. However,
addition of lucigenin
resulted in dose-dependent increases in reduction
of cytochrome
c (Table 2

).
Addition of up to 300 U · mL
-1 SOD had no
effect
on rates of cytochrome
c reduction, again revealing
direct O
2
-independent
electron
transfer from lucigenin to cytochrome
c. In contrast,
up to
50 µmol/L coelenterazine did not significantly enhance
rates of
cytochrome
c reduction.

View larger version (12K):
[in this window]
[in a new window]
|
Figure 1. SOD-inhibitable reduction of cytochrome
c by XO. Reaction mixtures contained 150 µmol/L
NADH, 50 mU · mL-1 XO in 50 mmol/L potassium
phosphate and 100 µmol/L EDTA buffer, pH 7.4. Addition of
20 µmol/L lucigenin (LUC) increased the rate of cytochrome
c reduction 5-fold. In the presence of 30 U ·
mL-1 SOD, lucigenin-enhanced cytochrome c
reduction was inhibited 43%.
|
|
Lucigenin-Enhanced Vascular Production of Oxidants
Endothelial cell monolayer
O2
production measured via
SOD-inhibitable cytochrome c reduction, in the presence or
absence of lucigenin, could not be determined reliably because of
complications induced by very low rates of cell
O2
release, SOD-insensitive direct
reduction of cytochrome c by cellular components, cytochrome
c adsorption to cell monolayers, and the reoxidation of
reduced cytochrome c by accumulating
H2O2. Therefore, the
extracellular release of
H2O2, the product of
both enzymatic and spontaneous dismutation of
O2
, was used to reflect changes in
cellular O2
formation.41 Preliminary studies revealed that
lucigenin interfered with assay systems for
H2O2 that relied on
peroxidase-mediated oxidation of phenolic compounds, eg,
p-hydroxyphenylacetic acid. Thus, extracellular release of
H2O2 from BAEC was measured
by reaction of medium removed from cell monolayers with ammonium
ferrous sulfate and potassium thiocyanate.37 38
Exposure of BAEC to 50 and 250 µmol/L lucigenin resulted in
significant increases in the extracellular release of
H2O2 over time (Figure 2
), demonstrating a
lucigenin-dependent acceleration in the rates of either extracellular
or intracellular partial reduction of oxygen to
O2
and its dismutation product,
H2O2. In the absence of
cells, there was no increase in
H2O2 concentrations over
time (not shown), establishing lucigenin-dependent enhancement of
H2O2 formation as a
cell-associated event. The addition of catalase (200 U ·
mL-1) to reactions completely inhibited
H2O2 accumulation (not
shown).

View larger version (36K):
[in this window]
[in a new window]
|
Figure 2. Lucigenin-dependent H2O2
release from BAECs. BAECs were thoroughly rinsed and then incubated
with lucigenin for 3 hours at 37°C. Medium was removed and acidified
for measurement of H2O2. Cells were assayed for
protein content. Data are mean±SEM of 3 separate experiments repeated
in triplicate. *P<0.05 compared with control.
|
|
The addition of lucigenin (100 and 250 µmol/L) to isolated
aortic rings inhibited endothelium-dependent relaxation
(Figure 3A
). The presence of SOD in the
organ bath restored responsiveness to ACh, indicating
lucigenin-enhanced vascular production of
O2
, which in turn reacted with the
added SOD.5 Because of the concern that the hyperoxic
environment (95% O2, 5%
CO2) in which vascular relaxation studies are
typically performed may enhance O2
formation42 43 44 and artifactually increase vascular
reduction of lucigenin and thus rates of formation of partially reduced
oxygen species, studies were also conducted in 21%
O2, 5% CO2 mixtures, with
similar results (not shown). In contrast, addition of coelenterazine to
cultured endothelial cells had no effect on
extracellular H2O2 release
(Table 3
) or
endothelium-dependent relaxation (Figure 3B
).

View larger version (19K):
[in this window]
[in a new window]
|
Figure 3. Influence of lucigenin or coelenterazine on
endothelium-dependent relaxation of thoracic aortic
rings. A, Lucigenin (100 and 250 µmol/L) was added to the tissue
bath, and vascular relaxation responses to ACh were determined. CuZn
SOD (200 U · mL-1)restored lucigenin (250
µmol/L) inhibited endothelium-dependent relaxation.
P<0.05 compared with control;
*P<0.05 compared with control and 100 µmol/L
lucigenin. B, Addition of coelenterazine (10 and 50 µmol/L) had
no effect on the response to ACh. Numbers in parentheses refer to
number of animals from which vessels were used to construct curves.
Data are mean±SEM.
|
|
Coelenterazine-Dependent Chemiluminescence
To characterize the utility of coelenterazine as a probe for
O2
and other biologically relevant
oxidants, chemiluminescence experiments were performed. The
O2
and
H2O2 generating system of
acetaldehyde and XO was used to limit the accumulation of purine
oxidation products (eg, urate) that scavenge ·NO- and XO-derived
reactive species.45 Coelenterazine-enhanced
chemiluminescence yields were linearly related to coelenterazine
concentrations ranging from 0.5 to 3 µmol/L (Figure 4
). Chemiluminescence was directly
proportional to increasing rates of
O2
and
H2O2 formation by XO up to
14 µmol/L · min-1
O2
(Figure 5
). Addition of catalase had no effect on
coelenterazine chemiluminescence from acetaldehyde and XO (Figure 6
), nor did bolus addition of up to
1 mmol/L H2O2 (not
shown). In contrast, 20 U · mL-1 SOD
fully inhibited chemiluminescence (Figure 6
). Together, these
data confirm that under these conditions coelenterazine
chemiluminescence was dependent on
O2
generation alone and not
H2O2, as previously
reported for an XO plus hypoxanthine reaction
mixture.33

View larger version (9K):
[in this window]
[in a new window]
|
Figure 4. Superoxide-dependent chemiluminescence as a
function of coelenterazine concentration. Reactions consisted of
120 µmol/L acetaldehyde, 8 mU · mL-1 XO
(generating 7 µmol/L · min-1
O2 ) and varying concentrations of
coelenterazine in 50 mmol/L potassium phosphate buffer, pH 7.4, at
37°C.
|
|

View larger version (9K):
[in this window]
[in a new window]
|
Figure 5. Coelenterazine-enhanced chemiluminescence as a
function of rate of superoxide generation. Reaction mixtures contained
4 µmol/L coelenterazine, 120 µmol/L acetaldehyde, and
varying concentrations of XO in 50 mmol/L potassium phosphate
buffer, pH 7.4, at 37°C.
|
|

View larger version (11K):
[in this window]
[in a new window]
|
Figure 6. Influence of hydrogen peroxide and superoxide on
coelenterazine-enhanced chemiluminescence. Reaction mixtures contained
8 µmol/L coelenterazine, 120 µmol/L acetaldehyde, and 8
mU · mL-1 XO (generating 7 µmol/L ·
min-1 O2 ). Where indicated, 200
U · mL-1 catalase and 20 U ·
mL-1 SOD were added.
|
|
Repeated bolus addition of ·NO to this
O2
-generating system resulted in an
initial decrease in the chemiluminescent signal, followed by a
transient increase (Figure 7A
). This
suggests that ·NO inhibits the chemiluminescence yield of
O2
and coelenterazine, whereas the
product of ·NO and O2
reaction, ONOO-, also stimulated coelenterazine
chemiluminescence. This was confirmed by bolus addition of 10
µmol/L ONOO-, which resulted in a rapid
increase and subsequent decay of coelenterazine chemiluminescence
(Figure 7B
), whereas the decomposition products of
ONOO-, primarily nitrate and nitrite, did not
stimulate chemiluminescence.

View larger version (16K):
[in this window]
[in a new window]
|
Figure 7. The effect of ·NO and ONOO- on
superoxide-dependent coelenterazine chemiluminescence. A, Reaction
mixture contained 1 µmol/L coelenterazine, 120 µmol/L
acetaldehyde, and 2 mU · mL-1 XO (generating
1.6 µmol/L · min-1
O2 ). Where indicated, 1.6 µmol/L ·NO
was added. B, Reaction mixture contained 1 µmol/L coelenterazine
and bolus addition of 10 µmol/L ONOO- (solid line)
or decomposed ONOO- (dashed line), as indicated by the
arrow.
|
|
To test the utility of coelenterazine as a detector of vascular oxidant
production, isolated rat aortic segments were incubated with
DMNQ, a cell-permeant redox-cycling quinone that stimulates
O2
and
H2O2
production.46 After a 3-hour incubation,
coelenterazine (10 µmol/L) was added and chemiluminescence was
measured. Table 4
demonstrates an
increase in coelenterazine-enhanced chemiluminescence in rings treated
with DMNQ, compared with control rings. The membrane-permeable low
molecular weight SOD mimetic MnT2E47 decreased
chemiluminescence below control levels, suggesting ongoing oxidant
production under basal conditions, as noted
previously.2 4
 |
Discussion
|
|---|
Lucigenin, added in concentrations that are commonly used to
assess
O
2
production in
vascular systems (50 to 250 µmol/L),
increased both
endothelial cell
H
2O
2 production and
O
2
-dependent
inhibition of
endothelium-dependent relaxation. This demonstrates
that
lucigenin undergoes sequential cycles of reduction and reoxidation
by
cellular oxidoreductases with an ultimate acceleration of electron
transfer
to oxygen, leading to enhanced rates of vascular cell
production
of O
2
and
accumulation of its dismutation product,
H
2O
2. Reaction
of
lucigenin-derived O
2
with ·NO was
manifest by the
acute impairment of agonist-induced vascular relaxation
by lucigenin.
In aggregate, these properties of lucigenin will lead to
inaccurate
and artifactual overestimation of rates of tissue
O
2
production.
Although there are several approaches that sensitively detect the
reduction of oxygen to O2
, the low
intracellular steady-state levels of
O2
typically present in vascular
tissues have presented methodological challenges. First, the
efficient and redundant systems that have evolved to scavenge
O2
require that any detection
technique must be sensitive enough to effectively compete with these
intracellular and extracellular antioxidant components for reaction
with O2
. Second, there is often
inadequate access of probes to accurately assess changes in rates of
O2
production at
intracellular sites. For example, cytochrome c and native
CuZn SOD are excluded from the intracellular milieu and differentially
interact with cell surfaces on the basis of charge repulsion and size
exclusion.48 Third, many
O2
detection reactions are not
sufficiently specific, eg, ferricytochrome c reduction can
occur by O2
-independent direct
electron transfer (Table 2
),49 and reduced
cytochrome c can be reoxidized by cell-derived reactive
species such as H2O2 and
ONOO-.50 51 Finally, the
potential toxicity of some O2
probes
limits extended application in cell or tissue-based systems, as with
some spin traps used for electron paramagnetic resonance
spectroscopy.52
Lucigenin-enhanced chemiluminescence has been used because of its
potential to overcome the issues of intracellular access, purported
specificity for reaction with O2
,
and minimal cellular toxicity. The mechanism of
O2
-dependent lucigenin
chemiluminescence requires an initial 1-electron reduction of the
lucigenin di-cation to the mono-cation radical (Equation 1
),
with the mono-cation radical then reacting with
O2
to yield a dioxetane (Equation 2
). Spontaneous decomposition of the unstable dioxetane results
in the formation of an electronically excited acridone whose return to
ground state is accompanied by light emission. However, the mono-cation
radical can be formed via
O2
-independent electron transfer
reactions to then directly reduce oxygen, resulting in the accelerated
production of O2
and
reformation of the lucigenin di-cation (Equation 3
). Equation 2
may predominate under conditions that produce large amounts
of O2
, such as in XO plus xanthine
reaction mixtures or during the oxidative activation of neutrophils or
macrophages.32 The contribution of Equation 3
is significant, however, especially for systems that have
lower rates of O2
production.28 29 32 It was therefore important to
ascertain the potential for lucigenin-dependent modulation of
O2
generation in vascular
tissues.
 | (1) |
 | (2) |
 | (3) |
Numerous
enzymes, including XO, GO, aldehyde oxidase, lipoamide
dehydrogenase,
and endothelial ·NO synthase, have
been noted to directly
reduce the lucigenin di-cation to its
mono-cation radical
28 29 32 (Equation 1

).
Several of these systems result in lucigenin-dependent
stimulation of
the partial reduction of oxygen, as indicated
by accelerated rates of
oxygen consumption, O
2
production, and
H
2O
2 accumulation after
O
2
dismutation (Figures 1

and 3

, Tables 1
and 3

).
28 31 32 In
vascular diseases, there is an enhanced
infiltration of inflammatory
cells containing high levels of
NADPH oxidase and expression by
vascular cells of not only neutrophil-like
oxidases, but other oxidases
as well (eg, 15-lipoxygenase, XO),
all capable of
mediating direct electron transfer to lucigenin.
9 53 54 55 56 57 58 59 60
Within an intact cellular or tissue
environment, it has not been
determined with precision the enzyme(s)
that are responsible for the
observed "lucigenin reductase"
activity. Thus, in conditions that
have been associated with
elevated lucigenin chemiluminescence, the
apparent increase
in rates of O
2
production may in part be due to enhanced rates
of direct
reduction of lucigenin by electron transfer systems,
rather than a true
increase in tissue O
2
generation.
For example,
the hypercholesterolemic rabbit, a model
for atherosclerosis,
displays an increase in vascular
XO activity
59 and enhanced
lucigenin-dependent
chemiluminescence,
25 59 61 with increased
rates of
vascular O
2
production
proposed on the basis of these
increases in lucigenin
chemiluminescence. Importantly, other
lines of evidence also infer an
actual increase in steady-state
O
2
concentrations in this model, such as the partial normalization
of
impaired endothelium-dependent relaxation by
cell-permeant
SODs and inhibitors of XO.
5 62
However, the present observations
reveal that it is not feasible to
estimate actual rates of vascular
O
2
production using lucigenin. It remains possible that lucigenin
chemiluminescence
may serve as a nonspecific redox-sensitive marker for
the enhanced
electron transfer activities that are present in
various pathologies,
with the caveat that (from the present and
previous observations)
the estimation of
O
2
formation from such electron
transfer processes
may be artifactually enhanced. This is especially
the case for
mitochondria, organelles rich in flavoproteins that can
directly
reduce lucigenin to the mono-cation radical. This will enhance
nonrespiratory
mitochondrial oxygen consumption
32 because
of lucigenin-mediated
redirection of reducing equivalents to
O
2
and
H
2O
2
formation.
30 Thus, it would be expected that a significant
fraction of mitochondrial
lucigenin-dependent chemiluminescence is due
to direct respiratory
chain reduction of lucigenin, extramitochondrial
diffusion of
the mono-cation radical, and subsequent auto-oxidation to
O
2
.
This lucigenin-dependent
chemiluminescence would be inhibitable
by various electron transport
and flavoprotein inhibitors, as
well as by exogenously
added SOD.
63 Added SOD would not be
expected to inhibit
lucigenin chemiluminescence induced by "true"
respiratory
chain-derived O
2
, since it is a
mitochondria-impermeable
macromolecule and would not be anticipated to
outcompete the
already significant levels of respiratory
chain-associated endogenous
mitochondrial MnSOD.
Coelenterazine is a lipophilic luminophore originally isolated from the
coelenterate Aequorea and is the light-producing chromophore
in the aequorin complex.64 Coelenterazine and its
analogs, including CLA (2-methyl-6-phenyl-3,7-dihydroimidazo[1,2-
]
pyrazin-3-one) and MCLA
(2-methyl-6-(4-methoxyphenyl)-3,7-dihydroimidazo[1,2-
]
pyrazin-3-one), have been used to reflect
O2
production in both
purified enzyme reactions and activated
leukocytes.33 65 66 67 Studies of the chemical nature of the
excited species responsible for the chemiluminescence of pyrazin-3-one
compounds are incomplete but suggest that
O2
-stimulated chemiluminescence
occurs after direct oxidation to the acetamidopyrazine anion, which can
then also be protonated to form additional neutral light-emitting
excited species.68
There has not been a systematic evaluation of the potential for
coelenterazine or its analogs to undergo cycles of reduction and
reoxidation analogous to lucigenin, nor has there been a description of
the impact of other reactive species such as ·NO or
ONOO- on coelenterazine-dependent
chemiluminescence. Unlike lucigenin, there was no apparent enhancement
of O2
generation by coelenterazine
in vessel preparations, using the exquisitely sensitive modulation of
·NO-dependent signaling by O2
as
an indicator (Figure 3B
). Similar benefits have been observed
for the coelenterazine analog, CLA.69 Additional
confirmation that coelenterazine does not undergo cyclic auto-oxidation
reactions comes from lack of an effect by coelenterazine on rates of
partial reduction of oxygen by XO and cultured vascular
endothelial cells (Tables 1
and 3
). In
aggregate, these observations support the concept that
coelenterazine-dependent chemiluminescence is an oxidative process that
does not require an initial reduction of the luminescent
probe.66 68
The linear correlations between peak chemiluminescence response,
coelenterazine concentrations between 0.5 and 3 µmol/L, and
rates of SOD-inhibitable O2
generation demonstrate that coelenterazine is indeed a sensitive
indicator of O2
(Figures 4 through 6

). The coelenterazine chemiluminescence
responses to ·NO and ONOO- illustrate the care
that must be exercised when interpreting the measurement of reactive
species in biological tissues (Figure 7A
and 7B
). In systems in
which there is the likelihood of cogeneration of both
O2
and ·NO, additional control
reactions using SODs, ·NO synthase inhibitors, and
ONOO- scavengers, such as urate, ebselen, or
metalloporphyrins,34 70 must be performed to differentiate
the reactive species responsible for coelenterazine
chemiluminescence.
In summary, the use of lucigenin-enhanced chemiluminescence to estimate
rates of O2
formation in vascular
tissue must be viewed with caution, as its ability to undergo cycles of
reduction and oxidation contributes to
O2
production, confirming
previous studies using purified enzyme-substrate reaction
mixtures.28 29 31 Additionally, the properties of
oxidant-dependent coelenterazine chemiluminescence suggest its utility
as a sensitive and more reliable alternative probe in place of
lucigenin for the detection of O2
and related oxidants in biological systems.
 |
Acknowledgments
|
|---|
This study was supported by grants from the National Institutes
of
Health (K08 HL-03457; R01 HL-58115; R01 HL-51245, R01 HL-54815,
and
P60 HL-58418) and the American Heart Association (96015430).
Received January 15, 1999;
accepted February 24, 1999.
 |
References
|
|---|
-
Rubanyi GM, Vanhoutte PM. Superoxide anions and
hyperoxia inactivate endothelium-derived
relaxing factor. Am J Physiol. 1986;250:H822H827.[Abstract/Free Full Text]
-
Omar HA, Cherry PD, Mortelliti MP, Burke-Wolin TM,
Wolin MS. Inhibition of coronary artery superoxide dismutase
attenuates endothelium-dependent and -independent
nitrovasodilator relaxation. Circ Res. 1991;69:601608.[Abstract/Free Full Text]
-
Abrahamsson T, Brandt U, Marklund SL, Sjoqvist PO.
Vascular bound recombinant extracellular superoxide dismutase type C
protects against the detrimental effects of superoxide radicals on
endothelium-dependent arterial relaxation.
Circ Res. 1992;70:264271.[Abstract/Free Full Text]
-
Lynch SM, Frei B, Morrow JD, Roberts LJ, Xu A, Jackson
T, Reyna R, Klevay LM, Vita JA, Keaney JJ. Vascular superoxide
dismutase deficiency impairs endothelial vasodilator
function through direct inactivation of nitric oxide and increased
lipid peroxidation. Arterioscler Thromb Vasc Biol. 1997;17:29752981.[Abstract/Free Full Text]
-
White CR, Brock TA, Chang LY, Crapo JD, Briscoe P, Ku
DD, Bradley WA, Gianturco SH, Gore J, Freeman BA, Tarpey MM. Superoxide
and peroxynitrite in atherosclerosis. Proc Natl
Acad Sci U S A. 1994;91:10441048.[Abstract/Free Full Text]
-
Nakazono K, Watanabe N, Matsuno K, Sasaki J, Sato T,
Inoue M. Does superoxide underlie the pathogenesis of hypertension?
Proc Natl Acad Sci U S A. 1991;88:1004510048.[Abstract/Free Full Text]
-
Mullarkey CJ, Edelstein D, Brownlee M. Free radical
generation by early glycation products: a mechanism for accelerated
atherogenesis in diabetes. Biochem Biophys Res Commun. 1990;173:932939.[Medline]
[Order article via Infotrieve]
-
Oskarsson HJ, Hofmeyer TG. Diabetic human
platelets release a substance that inhibits platelet-mediated
vasodilation. Am J Physiol. 1997;273:H371H379.[Abstract/Free Full Text]
-
Rajagopalan S, Kurz S, Munzel T, Tarpey M, Freeman BA,
Griendling KK, Harrison DG. Angiotensin II-mediated
hypertension in the rat increases vascular superoxide
production via membrane NADH/NADPH oxidase activation:
contribution to alterations of vasomotor tone. J Clin
Invest. 1996;97:19161923.[Medline]
[Order article via Infotrieve]
-
Munzel T, Sayegh H, Freeman BA, Tarpey MM, Harrison DG.
Evidence for enhanced vascular superoxide anion production in
nitrate tolerance: a novel mechanism underlying tolerance and
cross-tolerance. J Clin Invest. 1995;95:187194.
-
Tsao PS, Buitrago R, Chan JR, Cooke JP. Fluid flow
inhibits endothelial adhesiveness: nitric oxide and
transcriptional regulation of VCAM-1. Circulation. 1996;94:16821689.[Abstract/Free Full Text]
-
Marumo T, Schini-Kerth VB, Fisslthaler B, Busse R.
Platelet-derived growth factor-stimulated superoxide anion
production modulates activation of transcription factor
NF-
B and expression of monocyte chemoattractant protein 1 in
human aortic smooth muscle cells. Circulation. 1997;96:23612367.[Abstract/Free Full Text]
-
Brawn K, Fridovich I. Superoxide radical and superoxide
dismutases: threat and defense. Acta Physiol Scand. 1980;492:918.
-
Lynch RE, Fridovich I. Permeation of the erythrocyte
stroma by superoxide radical. J Biol Chem. 1978;253:46974699.[Abstract/Free Full Text]
-
Rosen GM, Freeman BA. Detection of superoxide generated
by endothelial cells. Proc Natl Acad Sci
U S A. 1984;81:72697273.[Abstract/Free Full Text]
-
Marklund SL, Karlsson K. Extracellular-superoxide
dismutase: distribution in the body and therapeutic applications.
Adv Exp Med Biol. 1990;264:14.[Medline]
[Order article via Infotrieve]
-
Skulachev VP. Membrane-linked systems preventing
superoxide formation. Biosci Rep. 1997;17:347366.[Medline]
[Order article via Infotrieve]
-
Halliwell B. How to characterize an antioxidant: an
update. Biochem Soc Symp. 1995;61:73101.[Medline]
[Order article via Infotrieve]
-
Rice-Evans CA, Diplock AT. Current status of
antioxidant therapy. Free Radic Biol Med. 1993;15:7796.[Medline]
[Order article via Infotrieve]
-
Corbisier P, Houbion A, Remacle J. A new technique for
highly sensitive detection of superoxide dismutase activity by
chemiluminescence. Anal Biochem. 1987;164:240247.[Medline]
[Order article via Infotrieve]
-
Storch J, Ferber E. Detergent-amplified
chemiluminescence of lucigenin for determination of superoxide anion
production by NADPH oxidase and xanthine oxidase. Anal
Biochem. 1988;169:262267.[Medline]
[Order article via Infotrieve]
-
Minkenberg I, Ferber E. Lucigenin-dependent
chemiluminescence as a new assay for NAD(P)H-oxidase activity in
particulate fractions of human polymorphonuclear leukocytes.
J Immunol Methods. 1984;71:6167.[Medline]
[Order article via Infotrieve]
-
Gyllenhammar H. Lucigenin chemiluminescence in the
assessment of neutrophil superoxide production. J
Immunol Methods. 1987;97:209213.[Medline]
[Order article via Infotrieve]
-
Archer SL, Nelson DP, Weir EK. Detection of
activated O2 species in vitro and in rat
lungs by chemiluminescence. J Appl Physiol. 1989;67:19121921.[Abstract/Free Full Text]
-
Ohara Y, Peterson TE, Harrison DG.
Hypercholesterolemia increases
endothelial superoxide anion production.
J Clin Invest. 1993;91:25462551.
-
Pagano PJ, Tornheim K, Cohen RA. Superoxide anion
production by rabbit thoracic aorta: effect of
endothelium-derived nitric oxide. Am J
Physiol. 1993;265:H707H712.[Abstract/Free Full Text]
-
Faulkner K, Fridovich I. Luminol and lucigenin as
detectors for O2. Free
Radic Biol Med. 1993;15:447451.[Medline]
[Order article via Infotrieve]
-
Liochev SI, Fridovich I. Lucigenin
(bis-N-methylacridinium) as a mediator of superoxide anion
production. Arch Biochem Biophys. 1997;337:115120.[Medline]
[Order article via Infotrieve]
-
Vasquez-Vivar J, Hogg N, Pritchard KA Jr, Martasek P,
Kalyanaraman B. Superoxide anion formation from lucigenin: an electron
spin resonance spin-trapping study. FEBS Lett. 1997;403:127130.[Medline]
[Order article via Infotrieve]
-
Heiser I, Muhr A, Elstner EF. Production of
OH-radical-type oxidant by lucigenin. Z Naturforsch C. 1998;53:914.
-
Liochev SI, Fridovich I. Lucigenin as mediator of
superoxide productionrevisited. Free Radic Biol
Med. 1998;25:926928.[Medline]
[Order article via Infotrieve]
-
Li Y, Zhu H, Kuppusamy P, Roubaud V, Zweier JL, Trush
MA. Validation of lucigenin (bis-N-methylacridinium) as a
chemilumigenic probe for detecting superoxide anion radical
production by enzymatic and cellular systems. J Biol
Chem. 1998;273:20152023.[Abstract/Free Full Text]
-
Lucas M, Solano F. Coelenterazine is a superoxide
anion-sensitive chemiluminescent probe: its usefulness in the assay of
respiratory burst in neutrophils. Anal Biochem. 1992;206:273277.[Medline]
[Order article via Infotrieve]
-
Castro L, Alvarez MN, Radi R. Modulatory role of nitric
oxide on superoxide-dependent luminol chemiluminescence. Arch
Biochem Biophys. 1996;333:179188.[Medline]
[Order article via Infotrieve]
-
Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman
BA. Apparent hydroxyl radical production by peroxynitrite:
implications for endothelial injury from nitric oxide
and superoxide. Proc Natl Acad Sci U S A. 1990;87:16201624.[Abstract/Free Full Text]
-
Hughes MN, Nicklin HG. The chemistry of pernitrites, I:
kinetics of decomposition of pernitrous acid. J Chem Soc
(Lond). 1968;A:450452.
-
Thurman RG, Ley HG, Scholz R. Hepatic microsomal
ethanol oxidation: hydrogen peroxide formation and the role of
catalase. Eur J Biochem. 1972;25:420430.[Medline]
[Order article via Infotrieve]
-
Shi M, Gozal E, Choy HA, Forman HJ. Extracellular
glutathione and gamma-glutamyl transpeptidase prevent
H2O2-induced injury by
2,3-dimethoxy-1,4-naphthoquinone. Free Radic Biol Med. 1993;15:5767.[Medline]
[Order article via Infotrieve]
-
McCord JM, Fridovich I. Superoxide dismutase: an
enzymic function for erythrocuprein (hemocuprein). J Biol
Chem. 1969;244:60496055.[Abstract/Free Full Text]
-
Lane RD, Federman D, Flora JL, Beck BL.
Computer-assisted determination of protein concentrations from
dye-binding and bicinchoninic acid protein assays performed in
microtiter plates. J Immunol Methods. 1986;92:261270.[Medline]
[Order article via Infotrieve]
-
Paler-Martinez A, Panus PC, Chumley PH, Ryan U, Hardy
MM, Freeman BA. Endogenous xanthine oxidase does not
significantly contribute to vascular endothelial
production of reactive oxygen species. Arch Biochem
Biophys. 1994;311:7985.[Medline]
[Order article via Infotrieve]
-
Freeman BA, Crapo JD. Hyperoxia increases oxygen
radical production in rat lungs and lung mitochondria.
J Biol Chem. 1981;256:1098610992.[Free Full Text]
-
Turrens JF, Freeman BA, Levitt JG, Crapo JD. The effect
of hyperoxia on superoxide production by lung submitochondrial
particles. Arch Biochem Biophys. 1982;217:401410.[Medline]
[Order article via Infotrieve]
-
Yusa T, Crapo JD, Freeman BA. Hyperoxia enhances lung
and liver nuclear superoxide generation. Biochim Biophys
Acta. 1984;798:167174.[Medline]
[Order article via Infotrieve]
-
Lynch RE, Fridovich I. Effects of superoxide on the
erythrocyte membrane. J Biol Chem. 1978;253:18381845.
-
Shi MM, Kugelman A, Iwamoto T, Tian L, Forman HJ.
Quinone-induced oxidative stress elevates glutathione and induces
gamma-glutamylcysteine synthetase activity in rat lung epithelial L2
cells. J Biol Chem. 1994;269:2651226517.[Abstract/Free Full Text]
-
Batinic-Haberle I, Liochev SI, Spasojevic I, Fridovich
I. A potent superoxide dismutase mimic: manganese
beta-octabromo-meso-tetrakis-(N-methylpyridinium-4-yl)
porphyrin. Arch Biochem Biophys. 1997;343:225233.[Medline]
[Order article via Infotrieve]
-
Radi R, Rubbo H, Bush K, Freeman BA. Xanthine oxidase
binding to glycosaminoglycans: kinetics and
superoxide dismutase interactions of immobilized xanthine
oxidase-heparin complexes. Arch Biochem Biophys. 1997;339:125135.[Medline]
[Order article via Infotrieve]
-
Fridovich I. Cytochrome c. In: Greenwald RA, ed.
Handbook of Methods for Oxygen Radical Research. Boca Raton,
Fla: CRC Press; 1985:121122.
-
Radi R, Thomson L, Rubbo H, Prodanov E. Cytochrome
c-catalyzed oxidation of organic molecules by hydrogen peroxide.
Arch Biochem Biophys. 1991;288:112117.[Medline]
[Order article via Infotrieve]
-
Thomson L, Trujillo M, Telleri R, Radi R. Kinetics of
cytochrome c2+ oxidation by peroxynitrite: implications for superoxide
measurements in nitric oxide-producing biological systems. Arch
Biochem Biophys. 1995;319:491497.[Medline]
[Order article via Infotrieve]
-
Rosen GM, Halpern HJ. Spin trapping biologically
generated free radicals: correlating formation with cellular injury.
Methods Enzymol. 1990;186:611621.[Medline]
[Order article via Infotrieve]
-
Li H, Cybulsky MI, Gimbrone MA Jr, Libby P. An
atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable
mononuclear leukocyte adhesion molecule, in rabbit aortic
endothelium. Arterioscler Thromb. 1993;13:197204.[Abstract/Free Full Text]
-
Kling D, Holzschuh T, Betz E. Recruitment and dynamics
of leukocytes in the formation of arterial intimal
thickening: a comparative study with normo- and
hypercholesterolemic rabbits.
Atherosclerosis. 1993;101:7996.[Medline]
[Order article via Infotrieve]
-
Rosenfeld ME, Tsukada T, Gown AM, Ross R. Fatty streak
initiation in Watanabe Heritable Hyperlipemic and comparably
hypercholesterolemic fat-fed rabbits.
Arteriosclerosis. 1987;7:923.[Abstract]
-
O'Brien KD, McDonald TO, Chait A, Allen MD, Alpers CE.
Neovascular expression of E-selectin, intercellular adhesion
molecule-1, and vascular cell adhesion molecule-1 in human
atherosclerosis and their relation to intimal leukocyte
content. Circulation. 1996;93:672682.[Abstract/Free Full Text]
-
De Keulenaer GW, Alexander RW, Ushio-Fukai M, Ishizaka
N, Griendling KK. Tumour necrosis factor alpha activates a
p22phox-based NADH oxidase in vascular smooth muscle. Biochem
J. 1998;329:653657.
-
Fukui T, Ishizaka N, Rajagopalan S, Laursen JB, Capers
Q 4th, Taylor WR, Harrison DG, de Leon H, Wilcox JN, Griendling KK.
p22phox mRNA expression and NADPH oxidase activity are increased in
aortas from hypertensive rats. Circ Res. 1997;80:4551.[Abstract/Free Full Text]
-
White CR, Darley-Usmar V, Berrington WR, McAdams M,
Gore JZ, Thompson JA, Parks DA, Tarpey MM, Freeman BA. Circulating
plasma xanthine oxidase contributes to vascular dysfunction in
hypercholesterolemic rabbits. Proc Natl Acad Sci
U S A. 1996;93:87458749.[Abstract/Free Full Text]
-
Yla-Herttuala S, Rosenfeld ME, Parthasarathy S, Sigal
E, Sarkioja T, Witztum JL, Steinberg D. Gene expression in
macrophage-rich human atherosclerotic lesions:
15-lipoxygenase and acetyl low density lipoprotein
receptor messenger RNA colocalize with oxidation specific lipid-protein
adducts. J Clin Invest. 1991;87:11461152.
-
Ohara Y, Peterson TE, Sayegh HS, Subramanian RR, Wilcox
JN, Harrison DG. Dietary correction of
hypercholesterolemia in the rabbit normalizes
endothelial superoxide anion production.
Circulation. 1995;92:898903.[Abstract/Free Full Text]
-
Mugge A, Elwell JH, Peterson TE, Hofmeyer TG, Heistad
DD, Harrison DG. Chronic treatment with polyethylene-glycolated
superoxide dismutase partially restores
endothelium-dependent vascular relaxations in
cholesterol-fed rabbits. Circ Res. 1991;69:12931300.[Abstract/Free Full Text]
-
Li Y, Trush MA. Diphenyleneiodonium, an NAD(P)H oxidase
inhibitor, also potently inhibits mitochondrial reactive
oxygen species production. Biochem Biophys Res
Commun. 1998;253:295299.[Medline]
[Order article via Infotrieve]
-
Shimomura O, Johnson FH. Peroxidized coelenterazine,
the active group in the photoprotein aequorin. Proc Natl Acad Sci
U S A. 1978;75:26112615.[Abstract/Free Full Text]
-
Nakano M. Assay for superoxide dismutase based on
chemiluminescence of luciferin analog. Methods Enzymol. 1990;186:227232.[Medline]
[Order article via Infotrieve]
-
Nakano M. Determination of superoxide radical and
singlet oxygen based on chemiluminescence of luciferin analogs.
Methods Enzymol. 1990;186:585591.[Medline]
[Order article via Infotrieve]
-
Teranishi K, Shimomura O. Coelenterazine analogs as
chemiluminescent probe for superoxide anion. Anal Biochem. 1997;249:3743.[Medline]
[Order article via Infotrieve]
-
Goto T, Inoue S, Sugiura S, Nishikawa K, Isobe M, Abe
Y. Cypridina bioluminescence, V: structure of